SCHEMBL26969488

SCHEMBL26969488

Cc1ccc(S(=O)(=O)n2cc(-c3nc(Br)cs3)c3nc(C)ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.40
KDM4E B2RXH2 1/20 0.39
UBE2N P61088 1/20 0.39
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ALDH3A1 P30838 2/20 0.35
POLB P06746 1/20 0.35
HTT P42858 1/20 0.35
NOD1 Q9Y239 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTR6 P50406 4/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 3/20 0.33
DRD2 P14416 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
EGFR P00533 1/20 0.33
MAPT P10636 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KLK7 P49862 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29604850 0.83 L3MBTL1 (0.37) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL29604811 0.82 L3MBTL1 (0.38) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL29606663 0.81 L3MBTL1 (0.37) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL29605034 0.80 L3MBTL1 (0.44) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL26969417 0.80 CA1 (0.50) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL29604530 0.77 L3MBTL1 (0.41) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL26969413 0.75 KDM4E (0.44) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL29606068 0.74 L3MBTL1 (0.37) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL29605374 0.73 L3MBTL1 (0.37) L3MBTL1KDM4EUBE2NCA1CA2
SCHEMBL26969480 0.73 L3MBTL1 (0.37) L3MBTL1KDM4EUBE2NCA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230416256-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE JANSSEN PHARAMCEUTICA NV (BE) 2023-12-28 US disclosed
EP-4244224-A1 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE JANSSEN Pharmaceutica NV (BE) 2023-09-20 EP disclosed
WO-2022104348-A1 SMALL MOLECULE INHIBITORS OF NF-KB INDUCING KINASE JANSSEN PHARMACEUTICA NV (BE) 2022-05-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230416256-A1 SMALL MOLECULE INHIBITORS OF NF-kB INDUCING KINASE NFKBIA, IKBKB, NFRKB L3MBTL1 2176/4885KDM4E 1209/4885UBE2N 2540/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.